Main Article Content

Nedya Bellinawati

Diabetic foot ulcer is a chronic and frequent complication in diabetic patients. Foot ulcers occur in 15-25% of people with diabetes, and most of them require amputation. Conventional treatments for DFU have not been effective enough to reduce the amputation rates. Thus, an effective method to accelerate the healing of diabetic foot ulcers is required. Recently, stem cells have emerged as a promising adjuvant therapy. One of the numerous types of stem cells used in chronic wound healing therapy is Mesenchymal Stem Cells (MSCs). MSCs may be associated with shorter wound healing time, rapid tissue regeneration, and reduced risk of lower limb amputation through all mechanisms. This article summarizes and critically reviews the published literature on the use of MSCs to enhance chronic wound healing in DFUs.

Keywords: MSC's penyembuhan luka ulkus kaki diabetik Mesenchymal Stem Cells diabetic foot ulcer
Soelistijo S. Guidelines for the Management and Prevention of Adult Type 2 Diabetes Mellitus in Indonesia 2021. Glob Initiat Asthma [Internet]. 2021;46. Available from:
Ibrahim A. IDF Clinical Practice Recommendations on the Diabetic Foot: A guide for healthcare professionals. Vol. 127, Diabetes Research and Clinical Practice. 2017. 285–287 p.
Hunt D. Diabetes: foot ulcers and amputations. BMJ Clinic Evid. 2009;2009(November 2007):1–16.
Almeida SA de, Silveira MM, Do PF, Santo E, Pereira RDC, Salomé GM. Assessment of the quality of life of patients with diabetes mellitus and foot ulcers. Rev Bras Cir Plast. 2013;28(1):142–6.
Isakson M, De Blacam C, Whelan D, McArdle A, Clover AJP. Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential. Stem Cells Int. 2015;2015.
Sagita S. Controversy over Stem Cell Research and Therapy from the View of Science Ethics. J Indonesian Philosophy. 2020;3(2):54–62.
Djauhari T. Stem Cells. Vol. 6, Saintika Medika. 2012.
Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: Past, present, and future. Stem Cell Res Ther. 2019;10(1).
El Hage R, Knippschild U, Arnold T, Hinterseher I. Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot Ulcer. Biomedicines. 2022;10(7):1–22.
Shu X, Shu S, Tang S, Yang L, Liu D, Li K, et al. The efficiency of stem cell-based therapy in the treatment of diabetic foot ulcers: A meta-analysis. Endocr J. 2018;65(4):403–13.
Zhao L, Guo Z, Chen K, Yang W, Wan X, Zeng P, et al. Combined Transplantation of Mesenchymal Stem Cells and Endothelial Colony-Forming Cells Accelerates Refractory Diabetic Foot Ulcer Healing. Stem Cells Int. 2020;2020.
Chen G, Yue A, Ruan Z, Yin Y, Wang R, Ren Y, et al. Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly. Stem Cell Res Ther [Internet]. 2015;6(1):1–7. Available from:
AI A, S. AN, PH B, M. AS, C. B, E. H, et al. Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling. Stem Cell Res Ther. 2014;5(1):1–13.
Nalisa DL, Moneruzzaman M, Changwe GJ, Mobet Y, Li LP, Ma YJ, et al. Stem Cell Therapy for Diabetic Foot Ulcers: Theory and Practice. J Diabetes Res. 2022;2022.
Lee DE, Ayoub N, Agrawal DK. Mesenchymal stem cells and cutaneous wound healing: Novel methods to increase cell delivery and therapeutic efficacy. Stem Cell Res Ther [Internet]. 2016;7(1):1–8. Available from:
Kong P. Placental mesenchymal stem cells accelerate wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biomed Biophys Res Commun [Internet]. 2013;438(2):410–9. Available from:
Jiayi Yang. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes Combined Pluronic F127 Hydrogel Promote Chronic Diabetic Wound Healing and Complete Skin Regeneration. Int Nanomedicine [Internet]. 2020;11(15):5911–26. Available from: